MediWound (MDWD) Operating Expenses (2013 - 2026)
MediWound (MDWD) posted Operating Expenses of $9.8 million for Q2 2026, up 30.86% on a QoQ basis from $7.5 million in Q1 2026, and up 38.78% year-over-year from $7.1 million in Q2 2025.
Analysis
MediWound (MDWD) Operating Expenses (2013 - 2026) Analysis & Trends
MediWound has reported Operating Expenses for 14 years, with the latest figure at $9.8 million in Q2 2026.
- On a quarterly basis, Operating Expenses rose 38.78% year-over-year to $9.8 million in Q2 2026; TTM through Jun 2026 was $29.8 million, a 21.59% increase from a year earlier, with the FY2025 full-year figure at $28.5 million, up 29.44% from the prior year.
- Operating Expenses was $9.8 million for Q2 2026 at MediWound, up from $7.5 million in the prior quarter.
- The five-year high for Operating Expenses was $9.8 million in Q2 2026, with the low at $3.2 million in Q1 2024.
- Average Operating Expenses over 5 years is $5.6 million, with a median of $5.5 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2026: Operating Expenses sank 34.03% in 2023, then jumped 60.21% in 2026.
- Over 5 years, Operating Expenses stood at $6.0 million in 2022, then decreased by 23.56% to $4.6 million in 2023, then jumped by 51.83% to $7.0 million in 2024, then slipped by 4.13% to $6.7 million in 2025, then surged by 45.87% to $9.8 million in 2026.
- The last three Operating Expenses figures came in at $9.8 million (Q2 2026), $7.5 million (Q1 2026), and $6.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 6.54 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 18.20 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 2.09 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 3.00 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -1.05 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 960.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.06 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 2.60 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 367.83 Mn |
| 10 | MediWound | 156.09 Mn | 120.75 Mn | 337,000.00 | 9.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.80 Mn |
| Mar 31, 2026 | 7.49 Mn |
| Dec 31, 2025 | 6.72 Mn |
| Sep 30, 2025 | 5.79 Mn |
| Jun 30, 2025 | 7.06 Mn |
| Mar 31, 2025 | 4.67 Mn |
| Dec 31, 2024 | 7.00 Mn |
| Sep 30, 2024 | 5.76 Mn |
| Jun 30, 2024 | 4.93 Mn |
| Mar 31, 2024 | 3.16 Mn |
| Dec 31, 2023 | 4.61 Mn |
| Sep 30, 2023 | 3.92 Mn |
| Jun 30, 2023 | 5.14 Mn |
| Mar 31, 2023 | 4.08 Mn |
| Dec 31, 2022 | 6.04 Mn |
| Sep 30, 2022 | 5.94 Mn |
| Jun 30, 2022 | 4.79 Mn |
| Mar 31, 2022 | 4.74 Mn |
| Dec 31, 2021 | 5.06 Mn |
| Sep 30, 2021 | 5.34 Mn |